Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis after the Allogeneic Stem Cell Transplantation-A Case Report

Mehrdad Payandeh¹, Sakineh Ghorbani², Afshin Karami³, Neda Veisi^4, , Ali Ghasemi⁴, Mohammad Mehdi Maadikhah⁴, Mojtaba Gorji⁵, Mehrnoush Aeinfar¹, Fatemeh Yari² and Masomeh Farhadi²

¹Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran

²Medical Bone Marrow Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

³Department of Hematology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

⁴Kermanshah University of Medical Sciences, Kermanshah, Iran

⁵Department of Hematology and Oncology, Lorestan University of Medical Sciences, School of Medicine, Khorramabad, Iran

Cite this paper:
Mehrdad Payandeh, Sakineh Ghorbani, Afshin Karami, Neda Veisi, Ali Ghasemi, Mohammad Mehdi Maadikhah, Mojtaba Gorji, Mehrnoush Aeinfar, Fatemeh Yari and Masomeh Farhadi. Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis after the Allogeneic Stem Cell Transplantation-A Case Report. American Journal of Cancer Prevention. 2018; 6(2):32-34. doi: 10.12691/ajcp-6-2-4

Abstract

Hemorrhagic cystitis (HC) is a significant clinical problem that occurs after allogeneic transplantation and is often refractory. The patient was a 40-year-old man who had HC after two months of transplantation of allogeneic stem cells. Several treatments were used to improve the patient, but no improvement. At the doctor's proposal, 5 sessions of Ozone therapy were performed for the patient, After the completion of the sessions, the clinical symptoms associated with HC disappeared completely. This study shows that HC treatment with ozone therapy is an effective and tolerable method and does not have any clinical complications.

Keywords:
hyperbaric oxygen therapy hemorrhagic cystitis allogeneic transplantation

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Tsuboi K, Kishi K, Ohmachi K, Yasuda Y, Shimizu T, Inoue H, et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone marrow transplantation. 2003; 32(9): 903.
[2]	Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis. Journal of pediatric urology. 2009; 5(4): 254-64.
[3]	Demesmay K, Tissot E, Bulabois C-E, Bertrand M-A, Racadot E, Woronoff-Lemsi M-C, et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation. 2002; 74(8): 1190-2.
[4]	de Gracia SR, Bento L, Gutiérrez A, Mañó LG, Novo A, Sampol A. The Use of Hyperbaric Oxygen Therapy for Refractory Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2016; 22(3): S354.
[5]	Urbaniak-Kujda D, Kapelko-Słowik K, Biernat M, Dybko J, Laszkowska M, Kuliczkowski K. The use of hyperbaric oxygen therapy in the treatment of hemorrhagic cystitis after allogeneic stem cell transplantation from an unrelated donor. International journal of hematology. 2015; 102(3): 364-7.
[6]	Hattori K, Yabe M, Matsumoto M, Kudo Y, Yasuda Y, Inoue H, et al. Successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 2001; 27(12).
[7]	Arnaout K, Patel N, Jain M, El-Amm J, Amro F, Tabbara IA. Complications of allogeneic hematopoietic stem cell transplantation. Cancer investigation. 2014; 32(7): 349-62.
[8]	Srivastava A, Nair S, Srivastava V, Balamurugan A, Jeyaseelan L, Chandy M, et al. Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis. Bone marrow transplantation. 1999; 23(5): 463-7.
[9]	Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006; 81(10): 1390-7.
[10]	Ordemann R, Naumann R, Geissler G, Bornhauser M, Schuler U, Ehninger G. Encouraging results in the treatment of haemorrhagic cystitis with estrogen-report of 10 cases and review of the literature. Bone marrow transplantation. 2000; 25(9): 981-5.13.
[11]	Pitto CM, Garcia-Perdomo HA. Interventions to treat hemorrhagic cystitis: a systematic review and meta-analysis. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2017; 25(7): 2043-6.
[12]	Bevers R, Kurth K, Bakker D. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. The Lancet. 1995; 346(8978): 803-5.
[13]	El-Zimaity M, Saliba R, Chan K, Shahjahan M, Carrasco A, Khorshid O, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 2004; 103(12): 4674-80.
[14]	Dellis A, Deliveliotis C, Kalentzos V, Vavasis P, Skolarikos A. Is there a role for hyberbaric oxygen as primary treatment for grade IV radiation-induced haemorrhagic cystitis? A prospective pilot-feasibility study and review of literature. International braz j urol. 2014; 40(3): 296-305.
[15]	Shao Y, Lu Gl, Shen Zj. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU international. 2012; 109(5): 691-4.